Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: Pre-hypertension, Hypertension

In brief

The goal of this study is to compare the effects of Potassium Magnesium Citrate to Potassium Chloride on blood pressure among patients with pre-hypertension or mild hypertension. We will also test whether Potassium Magnesium Citrate increases excretion of large amounts of sodium in the urine.

Key facts

Study ID

NCT01074918

Run by

University of Texas Southwestern Medical Center

People needed

0

Starts

2009-09-01

Expected to finish

2012-12-01

Last updated by the study team

2019-02-11

Who can join

Age: 21 and older, up to 95. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age greater than 21 years
• BMI > 18.5 kg/m2 and < 40 kg/m2
• Prehypertension and mild hypertension: BP systolic 120-159 mmHg, diastolic 80-95 mmHg
• Must agree to limit lifestyle changes including: 1) embarking on a new exercise or weight reduction program 2) altering alcohol intake during the trial.

You may not qualify if…

• Taking blood pressure lowering medication
• Diabetes mellitus
• Renal disease
• Active cardiac disease
• Active liver disease
• Chronic diarrhea
• Chronic NSAID use
• Active or suspected drug use
• Uncontrolled psychiatric disease
• HIV infection
• Missed more than 20% of clinic visits in the last yr
• Prescription of diuretics for any reason
• A patient taking nutritional supplements including multivitamins that is unwilling to discontinue them,\\
• Consumption of greater than 14 alcoholic beverages per week

Where it is running

• Dallas VA Medical Center — Dallas, Texas, United States
• UT Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.